Table 2

Clinical characteristics of the patient groups according to hs-CRP level (cardiovascular risk)
Compared groups and clinical data Group 1 Group 2 Group 3
low CVR medium CVR high CVR
n = 11 n = 30 n = 24
Males 7 (63.6%) 14 (46.7%) 4 (16.7%)
Females 4 (36.4%) 16 (53.3%) 20 (83.3%)*^
Ages (years) 56.6 ± 12.7 55.4 ± 9.9 57.2 ± 13.0
Hypertension 8 (72.7%) 26 (86.7%) 20 (83.3%)
Ischemic heart disease 3 (27.3%) 11 (36.7%) 6 (25.0%)
Myocardial infarct 1 (9.1%) 6 (20.0%) 1 (4.2%)
Cardiac failure 3 (27.3%) 11 (36.7%) 11 (45.8%)
IFG/IGT 5 (45.5%) 21 (70.0%) 12 (50.0%)
CKD 1 (9.1%) 7 (23.3%) 7 (29.2%)
Stroke 0 1 (3.3%) 2 (8.3%)
Cerebral arteries failure 1 (9.1%) 2 (6.7%) 0
Hyperuricemia 3 (27.3%) 11 (36.7%) 12 (50.0%)
Dyslipidemia 11 (100.0%) 29 (96.7%) 21 (87.5%)
Tobacco smoking 0 3 (10.0%) 2 (8.3%)
ACEI 9 (81.8%) 27 (90.0%) 11 (45.8%)^^
ARB 1 (9.1%) 6 (20.0%) 10 (41.7%)
Diuretics 6 (54.5%) 16 (53.3%) 16 (66.7%)
CCA 4 (36.4%) 10 (33.3%) 6 (25.0%)
BB 3 (27.3%) 10 (33.3%) 12 (50.0%)
Spironolactone 2 (18.2%) 5 (16.7%) 11 (45.8%)^
ARA 2 (18.2%) 4 (13.3%) 1 (4.2%)
ASA 1 (9.1%) 11 (36.7%) 5 (20.8%)
Hypolipemic treatmenta 10 (90.9%) *15 (50.0%) **10 (41.7%)

*p < 0.05; **p < 0.01; vs Group 1; ^P < 0.05 vs Group 2; ^^P < 0.01 vs Group 2; CVR – cardiovascular risk, a – statins and/or fibrates.

Stępień et al.

Stępień et al. Lipids in Health and Disease 2014 13:29   doi:10.1186/1476-511X-13-29

Open Data